Saario Susanna M, Palomäki Ville, Lehtonen Marko, Nevalainen Tapio, Järvinen Tomi, Laitinen Jarmo T
Department of Pharmaceutical Chemistry, Department of Physiology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland.
Chem Biol. 2006 Aug;13(8):811-4. doi: 10.1016/j.chembiol.2006.07.008.
Previous studies indicate that in brain tissue the endocannabinoid 2-AG is inactivated by monoglyceride lipase (MGL)-catalyzed hydrolysis, and a recent report has indicated that MGL activity could be specifically inhibited by URB754 . In the present study, URB754 failed to inhibit 2-AG hydrolysis in rat brain preparations. In addition, brain cryosections were employed to assess whether URB754 could facilitate the detection of 2-AG-stimulated G protein activity. Nevertheless, whereas pretreatment with PMSF readily allowed detection of 2-AG-stimulated G protein activity, URB754 was ineffective. In contrast to previous claims, brain FAAH activity was also resistant to URB754. Thus, in our hands URB754 was not able to block the endocannabinoid-hydrolyzing enzymes and cannot serve as a lead structure for future development of MGL-specific inhibitors.
先前的研究表明,在脑组织中,内源性大麻素2-花生四烯酸甘油酯(2-AG)通过甘油单酯脂肪酶(MGL)催化的水解作用失活,并且最近的一份报告指出,URB754可以特异性抑制MGL的活性。在本研究中,URB754未能抑制大鼠脑制备物中2-AG的水解。此外,采用脑冰冻切片来评估URB754是否能够促进对2-AG刺激的G蛋白活性的检测。然而,尽管用苯甲基磺酰氟(PMSF)预处理能够轻易检测到2-AG刺激的G蛋白活性,但URB754却没有效果。与先前的说法相反,脑脂肪酸酰胺水解酶(FAAH)的活性也对URB754具有抗性。因此,在我们的实验中,URB754无法阻断内源性大麻素水解酶,不能作为未来开发MGL特异性抑制剂的先导结构。